On November 5, Beijing Daqi Yuequan Bionic Technology Co., Ltd. announced the completion of its Pre-A round of financing, raising nearly 100 million RMB. This round was led by HONGTAI APLUS, with participation from Changxing Equity and Zhongguancun Development Qihang Innovation Investment Fund.
Led by Academicians, Dedicated to “Bionic Tension-Compression Robots”
Founded in 2022, Yuequan Bionic is a high-tech company developing general-purpose bionic humanoid robots. The company aims to promote the industrialization of high-degree-of-freedom bionic humanoid robotic motion systems and their core components. Its core business spans developing and commercializing technologies in bionic motion intelligence, bionic health systems and equipment, and humanoid robotics.
The founder, Ren Luquan, is an academician of the Chinese Academy of Sciences, a professor at Jilin University, and honorary president of the International Society of Bionic Engineering. He has long been engaged in bionic science and engineering research, proposing theories such as biological adhesion and detachment as well as bio-coupling phenomena. Ren has pioneered new fields in ground-based mechanical bionics and developed multiple innovative bionic technologies and products, including theories like detachment drag reduction and multi-factor coupling.
The co-founder, Ren Lei, is a tenured professor at the University of Manchester, a nationally distinguished expert, a Changjiang Scholar appointed by the Ministry of Education, and a professor at Jilin University. He is also the executive vice president of the International Society of Bionic Engineering. Ren Lei is globally recognized as the originator of the principles and technologies of bionic tension-compression robots. Supported by major national grants, he has successfully developed low-energy bionic walking technologies, bionic tension-compression dexterous hands, and humanoid robotic arms.
Currently, Yuequan Bionic has secured over 300 domestic and international patents in the field of bionic robotics. The company has successfully launched products such as the bionic tension-compression dexterous hand and robotic arm. It has also developed a prototype of a bionic lower-limb walking robot, demonstrating its walking capabilities in the laboratory. By 2025, the company plans to complete the development and assembly of a next-generation, highly bionic humanoid robot based on its bionic tension-compression technology system.
Breakthrough Technologies
– Bionic Tension-Compression Dexterous Hand: With 34 degrees of freedom, it can perform 98% of human hand movements, including complex daily tasks such as using chopsticks, unscrewing bottle caps, threading needles, and flipping through books. It achieves sub-millimeter precision and supports kilogram-level loads.
– Bionic Tension-Compression Robotic Arm: Designed with a tension-compression joint structure, it features 12 degrees of freedom and is equipped with a self-developed integrated artificial muscle actuator, achieving a load capacity of up to 50% of its weight.
– Bionic Lower-Limb Walking Robot: Integrating bionic ankle-foot systems and knee joint designs, this robot excels in impact resistance, low energy consumption, stability, and three-dimensional dynamic humanoid walking capabilities.
Accelerating Commercialization: Securing Multi-Million Yuan Orders
Despite officially launching operations just over a year ago, Yuequan Bionic has made rapid strides in commercialization. In 2024, leveraging breakthroughs in product development, the company successfully secured orders worth tens of millions of RMB, achieving industrial application of its humanoid robotics technologies across multiple fields.
– Energy Sector: Collaborating with the State Power Investment Corporation, the company integrates robotics and bionic technologies with drones and offshore wind power operations to enhance efficiency and safety.
– Special Operations: Yuequan Bionic provides robotic dexterous hand products for high-security defense projects, aiming to improve the intelligence and multi-task operational capabilities of unmanned defense and specialized robotic systems.
– Collaborations with Industry Leaders: The company is working with leading humanoid robotics firms to co-develop more flexible and agile joint-based humanoid robot products.
Looking ahead, the company plans to expand its bionic robotics technologies into sectors such as automotive, aerospace, and research education, further driving industrialization.
Broader Applications and Future Development
Beyond humanoid robotics, Yuequan Bionic is also venturing into the field of smart equipment derived from its bionic tension-compression technology, which is expected to become a second growth pillar. In the bionic prosthetics sector, the company focuses on using muscle electrical signals to achieve precise control.
Currently, Yuequan Bionic has delivered bionic ankle-foot products that have been well-received by clients. The company is committed to further industrializing these products and securing more orders.
In the future, Yuequan Bionic aims to deepen its research into muscle reconstruction and neural guidance technologies, providing users with more accurate bionic limb sensory experiences to enhance functionality and applicability.
Conclusion
Humanoid robotics, as an embodiment of interdisciplinary technologies, relies on continuous dedication to fundamental research and innovation. From academic research to technological application, academic leaders not only drive advancements in robotics technology but also accelerate the industrialization of research outcomes. Ultimately, success lies in transforming academic insights into societal practices, pushing technology forward in practical applications, and shaping a smarter future for society.
